1. FINAL
WYETH
WORLDWIDE NET REVENUE BY PRODUCT
THREE MONTHS ENDED DECEMBER 31, 2008
(000's)
(UNAUDITED)
DOMESTIC INTERNATIONAL TOTAL
4TH QTR 4TH QTR DOLLAR PERCENT 4TH QTR 4TH QTR DOLLAR PERCENT C$ C$ % 4TH QTR 4TH QTR DOLLAR PERCENT C$ C$ %
Wyeth Pharmaceuticals 2008 2007 CHANGE CHANGE 2008 2007 CHANGE CHANGE CHANGE CHANGE 2008 2007 CHANGE CHANGE CHANGE CHANGE
EFFEXOR $ 662,965 $ 645,579 $ 17,386 2.7% $ 238,618 $ 322,611 $ (83,993) -26.0% $ (42,282) -13.1% $ 901,583 $ 968,190 $ (66,607) -6.9% $ (24,896) -2.6%
PREVNAR 272,191 256,462 15,729 6.1% 329,933 299,199 30,734 10.3% 82,658 27.6% 602,124 555,661 46,463 8.4% 98,387 17.7%
ENBREL OUTSIDE U.S. & CANADA - - - N/A 597,789 564,976 32,813 5.8% 124,562 22.0% 597,789 564,976 32,813 5.8% 124,562 22.0%
ENBREL ALLIANCE REVENUE 284,813 248,107 36,706 14.8% 16,272 17,733 (1,461) -8.2% (1,273) -7.2% 301,085 265,840 35,245 13.3% 35,433 13.3%
NUTRITIONALS 1,131 721 410 56.9% 384,072 391,944 (7,872) -2.0% 25,626 6.5% 385,203 392,665 (7,462) -1.9% 26,036 6.6%
ZOSYN/TAZOCIN 188,451 146,668 41,783 28.5% 109,714 145,324 (35,610) -24.5% (18,674) -12.8% 298,165 291,992 6,173 2.1% 23,109 7.9%
PREMARIN FAMILY 237,877 233,829 4,048 1.7% 23,910 30,390 (6,480) -21.3% (1,499) -4.9% 261,787 264,219 (2,432) -0.9% 2,549 1.0%
PROTONIX RX 115,511 461,571 (346,060) -75.0% - - - N/A - N/A 115,511 461,571 (346,060) -75.0% (346,060) -75.0%
PROTONIX GENERIC 70,190 - 70,190 N/A - - - N/A - N/A 70,190 - 70,190 N/A 70,190 N/A
BENEFIX 67,340 57,508 9,832 17.1% 66,355 71,389 (5,034) -7.1% 5,478 7.7% 133,695 128,897 4,798 3.7% 15,310 11.9%
BMP-2 80,983 72,088 8,895 12.3% 3,265 2,387 878 36.8% 1,309 54.8% 84,248 74,475 9,773 13.1% 10,204 13.7%
CONTRACEPTIVES (including LYBREL) 7,624 13,262 (5,638) -42.5% 73,789 90,637 (16,848) -18.6% (7,597) -8.4% 81,413 103,899 (22,486) -21.6% (13,235) -12.7%
RAPAMUNE 49,690 49,164 526 1.1% 40,164 50,385 (10,221) -20.3% (3,129) -6.2% 89,854 99,549 (9,695) -9.7% (2,603) -2.6%
REFACTO/XYNTHA 18,397 17,657 740 4.2% 59,758 69,597 (9,839) -14.1% (1,174) -1.7% 78,155 87,254 (9,099) -10.4% (434) -0.5%
TYGACIL 36,128 28,011 8,117 29.0% 24,034 12,905 11,129 86.2% 13,720 106.3% 60,162 40,916 19,246 47.0% 21,837 53.4%
TORISEL 21,630 15,483 6,147 39.7% 13,143 562 12,581 N/A 12,270 N/A 34,773 16,045 18,728 116.7% 18,417 114.8%
PRISTIQ 32,497 - 32,497 N/A - - - N/A - N/A 32,497 - 32,497 N/A 32,497 N/A
subtotal 2,147,418 2,246,110 (98,692) -4.4% 1,980,816 2,070,039 (89,223) -4.3% 189,995 9.2% 4,128,234 4,316,149 (187,915) -4.4% 91,303 2.1%
OTHER PHARMACEUTICALS 34,522 94,991 (60,469) -63.7% 246,430 313,247 (66,817) -21.3% (58,557) -18.7% 280,952 408,238 (127,286) -31.2% (119,026) -29.2%
TOTAL WYETH PHARMACEUTICALS $ 2,181,940 $ 2,341,101 $ (159,161) -6.8% $ 2,227,246 $ 2,383,286 $ (156,040) -6.5% $ 131,438 5.5% $ 4,409,186 $ 4,724,387 $ (315,201) -6.7% $ (27,723) -0.6%
TOTAL FORT DODGE $ 96,760 $ 100,685 $ (3,925) -3.9% $ 140,108 $ 151,907 $ (11,799) -7.8% $ 9,432 6.2% $ 236,868 $ 252,592 $ (15,724) -6.2% $ 5,507 2.2%
Wyeth Consumer Healthcare
CENTRUM $ 83,988 $ 102,781 $ (18,793) -18.3% $ 85,881 $ 101,281 $ (15,400) -15.2% $ (2,919) -2.9% $ 169,869 $ 204,062 $ (34,193) -16.8% (21,712) -10.6%
ADVIL 127,776 139,670 (11,894) -8.5% 43,090 46,724 (3,634) -7.8% 4,448 9.5% 170,866 186,394 (15,528) -8.3% (7,446) -4.0%
CALTRATE 18,806 19,756 (950) -4.8% 42,120 40,917 1,203 2.9% 3,816 9.3% 60,926 60,673 253 0.4% 2,866 4.7%
ROBITUSSIN 66,720 55,606 11,114 20.0% 14,276 16,808 (2,532) -15.1% (568) -3.4% 80,996 72,414 8,582 11.9% 10,546 14.6%
CHAPSTICK 47,430 50,631 (3,201) -6.3% 6,044 8,995 (2,951) -32.8% (1,524) -16.9% 53,474 59,626 (6,152) -10.3% (4,725) -7.9%
PREPARATION H 21,945 22,528 (583) -2.6% 4,445 5,769 (1,324) -23.0% (597) -10.3% 26,390 28,297 (1,907) -6.7% (1,180) -4.2%
ADVIL COLD & SINUS 10,522 13,190 (2,668) -20.2% 10,879 12,665 (1,786) -14.1% 314 2.5% 21,401 25,855 (4,454) -17.2% (2,354) -9.1%
THERMACARE 15,924 - 15,924 N/A 4,236 - 4,236 N/A 5,044 N/A 20,160 - 20,160 N/A 20,968 N/A
OTHER 23,067 56,134 (33,067) -58.9% 75,116 93,092 (17,976) -19.3% (5,181) -5.6% 98,183 149,226 (51,043) -34.2% (38,248) -25.6%
TOTAL CONSUMER HEALTHCARE $ 416,178 $ 460,296 $ (44,118) -9.6% $ 286,087 $ 326,251 $ (40,164) -12.3% $ 2,833 0.9% $ 702,265 $ 786,547 $ (84,282) -10.7% $ (41,285) -5.2%
Wyeth
TOTAL PHARMACEUTICALS $ 2,181,940 $ 2,341,101 $ (159,161) -6.8% $ 2,227,246 $ 2,383,286 $ (156,040) -6.5% $ 131,438 5.5% $ 4,409,186 $ 4,724,387 $ (315,201) -6.7% $ (27,723) -0.6%
TOTAL FORT DODGE 96,760 100,685 (3,925) -3.9% 140,108 151,907 (11,799) -7.8% 9,432 6.2% 236,868 252,592 (15,724) -6.2% 5,507 2.2%
TOTAL CONSUMER HEALTHCARE 416,178 460,296 (44,118) -9.6% 286,087 326,251 (40,164) -12.3% 2,833 0.9% 702,265 786,547 (84,282) -10.7% (41,285) -5.2%
TOTAL WYETH $ 2,694,878 $ 2,902,082 $ (207,204) -7.1% $ 2,653,441 $ 2,861,444 $ (208,003) -7.3% $ 143,703 5.0% $ 5,348,319 $ 5,763,526 $ (415,207) -7.2% $ (63,501) -1.1%
Domestic / Int'l Percentage of Total 50% 50% 50% 50% 100% 100%
Notes:
- Certain reclassification adjustments have been made in 2007 in order to conform to the 2008 presentation.
- Alliance revenue attributable to Altace and the Cypher Stent have been included in Other Pharmaceuticals.

2. FINAL
WYETH
WORLDWIDE NET REVENUE BY PRODUCT
TWELVE MONTHS ENDED DECEMBER 31, 2008
(000's)
(UNAUDITED)
DOMESTIC INTERNATIONAL TOTAL
YTD YTD DOLLAR PERCENT YTD YTD DOLLAR PERCENT C$ C$ % YTD YTD DOLLAR PERCENT C$ C$ %
Wyeth Pharmaceuticals 2008 2007 CHANGE CHANGE 2008 2007 CHANGE CHANGE CHANGE CHANGE 2008 2007 CHANGE CHANGE CHANGE CHANGE
EFFEXOR $ 2,686,868 $ 2,577,062 $ 109,806 4.3% 1,240,988 1,216,842 $ 24,146 2.0% $ (19,893) -1.6% $ 3,927,856 $ 3,793,904 $ 133,952 3.5% $ 89,913 2.4%
PREVNAR 1,180,062 1,140,462 39,600 3.5% 1,535,445 1,298,594 236,851 18.2% 199,441 15.4% 2,715,507 2,439,056 276,451 11.3% 239,041 9.8%
ENBREL OUTSIDE U.S. & CANADA - - - N/A 2,592,918 2,044,628 548,290 26.8% 490,916 24.0% 2,592,918 2,044,628 548,290 26.8% 490,916 24.0%
ENBREL ALLIANCE REVENUE 1,134,741 940,614 194,127 20.6% 69,931 59,147 10,784 18.2% (2,572) -4.3% 1,204,672 999,761 204,911 20.5% 191,555 19.2%
NUTRITIONALS 4,352 3,514 838 23.8% 1,629,549 1,439,520 190,029 13.2% 167,413 11.6% 1,633,901 1,443,034 190,867 13.2% 168,251 11.7%
ZOSYN/TAZOCIN 701,105 575,775 125,330 21.8% 562,931 561,418 1,513 0.3% (11,537) -2.1% 1,264,036 1,137,193 126,843 11.2% 113,793 10.0%
PREMARIN FAMILY 965,897 948,668 17,229 1.8% 104,504 106,669 (2,165) -2.0% (202) -0.2% 1,070,401 1,055,337 15,064 1.4% 17,027 1.6%
PROTONIX RX 394,871 1,911,247 (1,516,376) -79.3% - - - N/A - N/A 394,871 1,911,247 (1,516,376) -79.3% (1,516,376) -79.3%
PROTONIX GENERIC 411,569 - 411,569 N/A - - - N/A - N/A 411,569 - 411,569 N/A 411,569 N/A
BENEFIX 262,818 273,541 (10,723) -3.9% 324,044 159,105 164,939 103.7% 172,590 108.5% 586,862 432,646 154,216 35.6% 161,867 37.4%
BMP-2 376,426 350,572 25,854 7.4% 13,195 8,314 4,881 58.7% 4,449 53.5% 389,621 358,886 30,735 8.6% 30,303 8.4%
CONTRACEPTIVES (including LYBREL) 42,459 50,740 (8,281) -16.3% 343,510 383,114 (39,604) -10.3% (54,852) -14.3% 385,969 433,854 (47,885) -11.0% (63,133) -14.6%
RAPAMUNE 190,876 189,134 1,742 0.9% 184,919 175,631 9,288 5.3% 4,977 2.8% 375,795 364,765 11,030 3.0% 6,719 1.8%
REFACTO/XYNTHA 73,677 73,428 249 0.3% 289,577 261,429 28,148 10.8% 13,188 5.0% 363,254 334,857 28,397 8.5% 13,437 4.0%
TYGACIL 132,531 97,277 35,254 36.2% 83,653 40,629 43,024 105.9% 41,302 101.7% 216,184 137,906 78,278 56.8% 76,556 55.5%
TORISEL 82,292 26,028 56,264 216.2% 39,825 565 39,260 N/A 38,944 N/A 122,117 26,593 95,524 359.2% 95,208 358.0%
PRISTIQ 66,512 - 66,512 N/A - - - N/A - N/A 66,512 - 66,512 N/A 66,512 N/A
subtotal 8,707,056 9,158,062 (451,006) -4.9% 9,014,989 7,755,605 1,259,384 16.2% 1,044,164 13.5% 17,722,045 16,913,667 808,378 4.8% 593,158 3.5%
OTHER PHARMACEUTICALS 209,027 525,988 (316,961) -60.3% 1,094,358 1,182,328 (87,970) -7.4% (124,068) -10.5% 1,303,385 1,708,316 (404,931) -23.7% (441,029) -25.8%
TOTAL WYETH PHARMACEUTICALS $ 8,916,083 $ 9,684,050 $ (767,967) -7.9% $ 10,109,347 $ 8,937,933 $ 1,171,414 13.1% $ 920,096 10.3% $ 19,025,430 $ 18,621,983 $ 403,447 2.2% $ 152,129 0.8%
TOTAL FORT DODGE $ 406,140 $ 446,210 $ (40,070) -9.0% $ 681,782 $ 595,521 $ 86,261 14.5% $ 71,246 12.0% $ 1,087,922 $ 1,041,731 $ 46,191 4.4% $ 31,176 3.0%
Wyeth Consumer Healthcare
CENTRUM $ 323,666 $ 332,842 $ (9,176) -2.8% 404,299 $ 372,053 $ 32,246 8.7% $ 18,754 5.0% $ 727,965 $ 704,895 $ 23,070 3.3% 9,578 1.4%
ADVIL 483,915 513,812 (29,897) -5.8% 189,354 170,287 19,067 11.2% 15,070 8.8% 673,269 684,099 (10,830) -1.6% (14,827) -2.2%
CALTRATE 75,309 73,030 2,279 3.1% 173,899 152,841 21,058 13.8% 13,083 8.6% 249,208 225,871 23,337 10.3% 15,362 6.8%
ROBITUSSIN 139,678 166,090 (26,412) -15.9% 59,041 54,251 4,790 8.8% 4,142 7.6% 198,719 220,341 (21,622) -9.8% (22,270) -10.1%
CHAPSTICK 109,569 112,652 (3,083) -2.7% 28,004 27,095 909 3.4% 2,369 8.7% 137,573 139,747 (2,174) -1.6% (714) -0.5%
PREPARATION H 87,308 85,454 1,854 2.2% 24,427 24,258 169 0.7% (650) -2.7% 111,735 109,712 2,023 1.8% 1,204 1.1%
ADVIL COLD & SINUS 29,948 33,039 (3,091) -9.4% 41,897 40,635 1,262 3.1% 1,220 3.0% 71,845 73,674 (1,829) -2.5% (1,871) -2.5%
THERMACARE 20,510 - 20,510 N/A 5,960 - 5,960 N/A 6,841 N/A 26,470 - 26,470 N/A 27,351 N/A
OTHER 122,498 190,505 (68,007) -35.7% 401,274 387,240 14,034 3.6% 1,944 0.5% 523,772 577,745 (53,973) -9.3% (66,063) -11.4%
TOTAL CONSUMER HEALTHCARE $ 1,392,401 $ 1,507,424 $ (115,023) -7.6% $ 1,328,155 $ 1,228,660 $ 99,495 8.1% $ 62,773 5.1% $ 2,720,556 $ 2,736,084 $ (15,528) -0.6% $ (52,250) -1.9%
Wyeth
TOTAL PHARMACEUTICALS $ 8,916,083 $ 9,684,050 $ (767,967) -7.9% $ 10,109,347 $ 8,937,933 $ 1,171,414 13.1% $ 920,096 10.3% $ 19,025,430 $ 18,621,983 $ 403,447 2.2% $ 152,129 0.8%
TOTAL FORT DODGE 406,140 446,210 (40,070) -9.0% 681,782 595,521 86,261 14.5% 71,246 12.0% 1,087,922 1,041,731 46,191 4.4% 31,176 3.0%
TOTAL CONSUMER HEALTHCARE 1,392,401 1,507,424 (115,023) -7.6% 1,328,155 1,228,660 99,495 8.1% 62,773 5.1% 2,720,556 2,736,084 (15,528) -0.6% (52,250) -1.9%
TOTAL WYETH $ 10,714,624 $ 11,637,684 $ (923,060) -7.9% $ 12,119,284 $ 10,762,114 $ 1,357,170 12.6% $ 1,054,115 9.8% $ 22,833,908 $ 22,399,798 $ 434,110 1.9% $ 131,055 0.6%
Domestic / Int'l Percentage of Total 47% 52% 53% 48% 100% 100%
Notes:
- Certain reclassification adjustments have been made in 2007 in order to conform to the 2008 presentation.
- Alliance revenue attributable to Altace and the Cypher Stent have been included in Other Pharmaceuticals.